SecBot SecBot
PRESS-RELEASE ·Filed Jun 16, 2026

CRON

Cronos Group Inc.
NEUTRAL
Impact 3/10
Horizonweeks Processed4mo ago WireGlobeNewswire
Press release · Activist
Actionable Insight • Neutral

The buyback is modest relative to market cap and spread over 11 months, so near-term price impact is likely minimal. Monitor quarterly filings for actual repurchase activity and any changes in cash position.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
CRON ▲ +17.60% at T+60d
NEUTRAL call +17.60% · α vs SPY +14.45% · entry $2.67 → $3.14
Entry = T+0 close
Jun 16, 2026
via day close
T+1d
+1.50%
call +1.50% · α +0.72%
$2.71
settled 4mo ago
T+5d
+1.50%
call +1.50% · α +2.54%
$2.71
settled 4mo ago
T+20d
+3.00%
call +3.00% · α +1.68%
$2.75
settled 3mo ago
T+60d
+17.60%
call +17.60% · α +14.45%
$3.14
settled 7w ago

Price Chart

Loading chart...

Executive Summary

Cronos Group announced that the TSX accepted its normal course issuer bid (NCIB), allowing repurchases on Canadian exchanges under its existing $50 million share repurchase program. The program, running from May 2026 to May 2027, covers up to 5.02% of outstanding shares and also received an OSC exemption for NASDAQ purchases. This is a routine capital allocation move with no financial results or guidance provided.

Key Financial Metrics

Deal Value
$50.0M

Key Facts

  • Share repurchase program of up to US$50 million approved by Board on May 8, 2026, commenced May 14, 2026, terminates May 13, 2027.
  • Maximum of 18,712,918 common shares (approximately 5.02% of 373 million outstanding as of June 1, 2026) may be repurchased.
  • TSX NCIB accepted; repurchases on TSX may begin June 19, 2026, limited to 25% of average daily trading volume (53,968 shares/day).
  • Ontario Securities Commission exemption obtained on June 15, 2026, allowing NASDAQ repurchases above Canadian limits.

Financial Impact

Up to $50 million share repurchase, representing ~5% of market cap ($990M).

dilution

Risk Factors

  • Buyback may not be fully executed if management prioritizes other uses of cash.
  • No financial results or guidance provided; fundamentals remain unknown.

Market Snapshot

Exchange
Nasdaq
Sector
Medicinal Chemicals & Botanical Products
Analyst Consensus
89% bullish (9 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3313018
9 reports for CRON
Performance horizon
80% Hit rate @ T+1 4 of 5 directional calls Went positive at some point 5 of 5 best @ T+5▲ +7.66%Oct 15, 2026
Filters
Rows
Reports for CRON — sortable, filterable
TypeNow
Oct 15, 2026
11d ago
8-K
BULLISH ★ 6/10
$3.20 $3.21▲ +0.31%▲ +1.42%$3.31 (+3.44%)
Oct 15, 2026
11d ago
Press Release
BULLISH ★ 6/10
$3.20 $3.21▲ +0.31%▲ +1.42%$3.31 (+3.44%)
Aug 6, 2026
11w ago
8-K
BULLISH ★ 7/10
$3.07 $3.10▲ +0.98%▲ +0.37%$3.31 (+7.82%)
Aug 6, 2026
11w ago
Press Release
MIXED ★ 6/10
$3.07 $3.10▲ +0.98%▲ +0.37%$3.31 (+7.82%)
Jul 16, 2026
14w ago
Press Release
NEUTRAL ★ 1/10
$2.75awaiting T+1—$3.31 (+20.36%)
Jun 16, 2026
18w ago
Press Release
NEUTRAL ★ 3/10
$2.67 $2.71▲ +1.50%▲ +0.72%$3.31 (+23.97%)
May 11, 2026
24w ago
8-K
BULLISH ★ 7/10
$2.75 $2.77▲ +0.73%▲ +0.86%$3.31 (+20.36%)
Apr 20, 2026
27w ago
Press Release
NEUTRAL ★ 1/10
$2.76awaiting T+1—$3.31 (+19.93%)
Feb 26, 2026
34w ago
8-K
BULLISH ★ 8/10
$2.67 $2.67· 0.00%▲ +0.45%$3.31 (+23.97%)
Showing 9 of 9

US Market Status

Market Closed — Opens in 2h 33m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 16, 2026